作者: Mcquiston Beth , Marino Jaime , Rogers Justin , Zhang Tianming , Datwyler Saul
DOI:
关键词: Biomarker (medicine) 、 Medicine 、 Magnetic resonance imaging 、 Pathology 、 Glial fibrillary acidic protein
摘要: Disclosed herein are methods that aid in the determination of whether to perform imaging, such as magnetic resonance imaging (MRI) or computerized tomography (CT) scan, on a human subject has sustained may have an injury head using early biomarker, ubiquitin carboxy-terminal hydrolase LI (UCH-L1), glial fibrillary acidic protein (GFAP), combination thereof. These involve detecting levels and changes UCH-L1 and/or GFAP samples taken from at time points within 24 hours after head.